Category: LSHTM CTU News
A CRASH-3 Trial Sub-Study Provides Evidence of TXA Benefit in TBI
Effect of tranexamic acid on intracranial haemorrhage and infarction in patients with traumatic brain injury: a randomised trial
Details
Art for Maternal Health Awareness
Sculpture artist, Moira Purver was commissioned by the WOMAN trial to create this spectacular bronze statue that depicts a mother on her knees holding her new baby in her arms just after giving birth.
Details
World Day of Remembrance for Road Traffic Victims
The researchers call urgent TXA treatment of all trauma victims, ideally at the scene of the crash, could prevent over 100,000 premature deaths each year worldwide.
Details
Tight K Trial is Recruiting!
TRIAL UPDATE (10/20): CONGRATULATIONS to the NHS Barts Health research team for recruiting their first patients into the TIGHTK Trial!
Details
Trauma Intact Results and News
Pharmacokinetic TRAUMAINTACT trial results show TXA is well tolerated & rapidly absorbed via IM route in bleeding trauma patients
Details
PREVENTT Trial Results and News
Preoperative IV iron is NOT superior to placebo to reduce need for blood transfusion when given to anaemia patients 10–42 days before elective major abdominal surgery
Details
HALT-IT Trial Results and News
HALT-IT trial found that TXA does NOT reduce deaths from stomach bleeding but increases the risk of thromboembolic events (deep vein thrombosis or pulmonary embolism)
Details
The CRASH-3 Results and News
Tranexamic Acid (TXA) is a safe, low cost, and widely available drug which could prevent deaths from TBI by as much as 20% depending on severity of the injury
Details
ISTH TV: The importance of giving TXA early to trauma & PPH patients
Watch Prof Ian Roberts on International Society on Thrombosis and Hemostasis Daily News, discussing the importance of giving TXA early to trauma & PPH patients
Details- 1
- 2